These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11312510)

  • 1. Detection of sulfur-containing impurities in pharmaceutical samples by high performance liquid chromatography/chemical reaction interface mass spectrometry.
    Eckers C; Abramson FP; Lecchi P
    Rapid Commun Mass Spectrom; 2001; 15(8):602-7. PubMed ID: 11312510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a method for the purity determination of (3beta,20R)-4,4-dimethylcholesta-8,14,24-trien-3-ol(FF-MAS) in pharmaceutical products containing recombinant human albumin.
    Jamali B; Andersen SG; Brødholt H; Wendel L; Bødstrup V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 810(2):251-7. PubMed ID: 15380722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of high-performance liquid chromatography/chemical reaction interface mass spectrometry for the analysis of conjugated metabolites: a demonstration using deuterated acetaminophen.
    Teffera Y; Abramson F
    Biol Mass Spectrom; 1994 Dec; 23(12):776-83. PubMed ID: 7841212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the utility of ion mobility separation in combination with high-pressure liquid chromatography/mass spectrometry to facilitate detection of trace impurities in formulated drug products.
    Eckers C; Laures AM; Giles K; Major H; Pringle S
    Rapid Commun Mass Spectrom; 2007; 21(7):1255-63. PubMed ID: 17340559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of unknown compounds in azithromycin bulk samples with liquid chromatography coupled to ion trap mass spectrometry.
    Debremaeker D; Visky D; Chepkwony HK; Van Schepdael A; Roets E; Hoogmartens J
    Rapid Commun Mass Spectrom; 2003; 17(4):342-50. PubMed ID: 12569445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the detection of degradants and impurities in pharmaceutical drug products by applying mass spectral and chromatographic searching.
    Freed AL; Kale U; Ando H; Rossi DT; Kingsmill CA
    J Pharm Biomed Anal; 2004 Jun; 35(4):727-38. PubMed ID: 15193717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LC determination of glimepiride and its related impurities.
    Khan MA; Sinha S; Vartak S; Bhartiya A; Kumar S
    J Pharm Biomed Anal; 2005 Oct; 39(5):928-43. PubMed ID: 16040224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategy for identification of leachables in packaged pharmaceutical liquid formulations.
    Pan C; Harmon F; Toscano K; Liu F; Vivilecchia R
    J Pharm Biomed Anal; 2008 Feb; 46(3):520-7. PubMed ID: 18180126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous separation and determination of coenzyme Q(10) and its process related impurities by NARP-HPLC and atmospheric pressure chemical ionization-mass spectrometry (APCI-MS).
    Nageswara Rao R; Kumar Talluri MV; Shinde DD
    J Pharm Biomed Anal; 2008 Jun; 47(2):230-7. PubMed ID: 18243624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LC-MS characterization of trace impurities contained in calcium folinate.
    Francese G; Corana F; Meneghetti O; Marazza F
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):757-63. PubMed ID: 15927438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and quantitative determination of impurities in piperaquine phosphate by HPLC and LC/MS/MS.
    Dongre VG; Karmuse PP; Ghugare PD; Gupta M; Nerurkar B; Shaha C; Kumar A
    J Pharm Biomed Anal; 2007 Jan; 43(1):186-95. PubMed ID: 16916594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Description and validation of a staggered parallel high performance liquid chromatography system for good laboratory practice level quantitative analysis by liquid chromatography/tandem mass spectrometry.
    King RC; Miller-Stein C; Magiera DJ; Brann J
    Rapid Commun Mass Spectrom; 2002; 16(1):43-52. PubMed ID: 11754246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of unknown impurities in simvastatin substance and tablets by liquid chromatography/tandem mass spectrometry.
    Vuletić M; Cindrić M; Koruznjak JD
    J Pharm Biomed Anal; 2005 Apr; 37(4):715-21. PubMed ID: 15797793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studying the reaction between clozapine and glutathione with element-selective detection.
    Teng J; Teffera Y; McLean M; Abramson FP
    Res Commun Mol Pathol Pharmacol; 1998 Feb; 99(2):131-42. PubMed ID: 9583088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of an unknown trace-level impurity in bulk drug of Seroquel by high-performance liquid chromatography combined with mass spectrometry.
    Xu H; Wang D; Sun C; Pan Y; Zhou M
    J Pharm Biomed Anal; 2007 Jun; 44(2):414-20. PubMed ID: 17420108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high-performance liquid chromatography-mass spectrometry method using a novel atmospheric pressure chemical ionization approach for the rapid simultaneous measurement of tacrolimus and cyclosporin in whole blood.
    Salm P; Taylor PJ; Rooney F
    Ther Drug Monit; 2008 Jun; 30(3):292-300. PubMed ID: 18520600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New ultraviolet signal actuated switching valve for the measurement of low level impurities by liquid chromatography/mass spectrometry.
    Wolff JC; Barr L; Moss P
    Rapid Commun Mass Spectrom; 1999; 13(23):2376-81. PubMed ID: 10567937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfur-specific detection of impurities in cimetidine drug substance using liquid chromatography coupled to high resolution inductively coupled plasma mass spectrometry and electrospray mass spectrometry.
    Evans EH; Wolff JC; Eckers C
    Anal Chem; 2001 Oct; 73(19):4722-8. PubMed ID: 11605853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micellar electrokinetic chromatography-electrospray ionization mass spectrometry for the identification of drug impurities.
    Mol R; Kragt E; Jimidar I; de Jong GJ; Somsen GW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Nov; 843(2):283-8. PubMed ID: 16837254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of serum uric acid using high-performance liquid chromatography (HPLC)/isotope dilution mass spectrometry (ID-MS) as a candidate reference method.
    Dai X; Fang X; Zhang C; Xu R; Xu B
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 857(2):287-95. PubMed ID: 17704012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.